This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2005 Nov 26;366(9500):1829-31.

doi: 10.1016/S0140-6736(05)67668-4.

After FIELD: should fibrates be used to prevent cardiovascular disease in diabetes?

Helen Colhoun¹

Affiliations

PMID: 16310536
DOI: 10.1016/S0140-6736(05)67668-4

Comment

After FIELD: should fibrates be used to prevent cardiovascular disease in diabetes?

Helen Colhoun. Lancet. 2005.

. 2005 Nov 26;366(9500):1829-31.

doi: 10.1016/S0140-6736(05)67668-4.

Author

Helen Colhoun¹

Affiliation

¹ Conway Institute, University College Dublin, Dublin 4, Ireland. helen.colhoun@ucd.ie

PMID: 16310536
DOI: 10.1016/S0140-6736(05)67668-4

No abstract available

PubMed Disclaimer

Comment on

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial.
Keech A, Simes RJ, Barter P, Best J, Scott R, Taskinen MR, Forder P, Pillai A, Davis T, Glasziou P, Drury P, Kesäniemi YA, Sullivan D, Hunt D, Colman P, d'Emden M, Whiting M, Ehnholm C, Laakso M; FIELD study investigators. Keech A, et al. Lancet. 2005 Nov 26;366(9500):1849-61. doi: 10.1016/S0140-6736(05)67667-2. Lancet. 2005. PMID: 16310551 Clinical Trial.

Similar articles

Fibrates after the FIELD study: Some answers, more questions.
Wierzbicki AS. Wierzbicki AS. Diab Vasc Dis Res. 2006 Dec;3(3):166-71. doi: 10.3132/dvdr.2006.025. Diab Vasc Dis Res. 2006. PMID: 17160911 Review.
Bedeutung und Therapie der Dyslipidämie beim Diabetes.
Bilz S. Bilz S. Ther Umsch. 2017;74(8):445-453. doi: 10.1024/0040-5930/a000939. Ther Umsch. 2017. PMID: 29461147 Review. German. No abstract available.
[Should the treatment of diabetic dyslipidemia be modified after the Action to Control Cardiovascular Risk in Diabetes Lipid study?].
Pérez A. Pérez A. Endocrinol Nutr. 2010 Dec;57(10):457-9. doi: 10.1016/j.endonu.2010.05.010. Epub 2010 Aug 4. Endocrinol Nutr. 2010. PMID: 20688585 Spanish. No abstract available.
Need for large scale randomised evidence about lowering LDL cholesterol in people with diabetes mellitus: MRC/BHF heart protection study and other major trials.
Armitage J, Collins R. Armitage J, et al. Heart. 2000 Oct;84(4):357-60. doi: 10.1136/heart.84.4.357. Heart. 2000. PMID: 10995396 Free PMC article. No abstract available.
A case report of a diabetic woman with very low HDL cholesterol.
Chaychi L, Kinlaw WB, Asztalos BF, Schaefer EJ. Chaychi L, et al. J Clin Lipidol. 2010 Mar-Apr;4(2):133-5. doi: 10.1016/j.jacl.2010.01.003. Epub 2010 Jan 29. J Clin Lipidol. 2010. PMID: 21122641 No abstract available.

See all similar articles

Cited by

Actionable Metabolic Pathways in Heart Failure and Cancer-Lessons From Cancer Cell Metabolism.
Karlstaedt A, Schiffer W, Taegtmeyer H. Karlstaedt A, et al. Front Cardiovasc Med. 2018 Jun 19;5:71. doi: 10.3389/fcvm.2018.00071. eCollection 2018. Front Cardiovasc Med. 2018. PMID: 29971237 Free PMC article. Review.
Plasma triglycerides predict ten-years all-cause mortality in outpatients with type 2 diabetes mellitus: a longitudinal observational study.
Miselli MA, Nora ED, Passaro A, Tomasi F, Zuliani G. Miselli MA, et al. Cardiovasc Diabetol. 2014 Oct 11;13:135. doi: 10.1186/s12933-014-0135-6. Cardiovasc Diabetol. 2014. PMID: 25301574 Free PMC article.
Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.
Kones R. Kones R. Vasc Health Risk Manag. 2013;9:617-70. doi: 10.2147/VHRM.S37119. Epub 2013 Oct 21. Vasc Health Risk Manag. 2013. PMID: 24174878 Free PMC article. Review.
Treatment of dyslipidemia in patients with type 2 diabetes.
Vijayaraghavan K. Vijayaraghavan K. Lipids Health Dis. 2010 Dec 20;9:144. doi: 10.1186/1476-511X-9-144. Lipids Health Dis. 2010. PMID: 21172030 Free PMC article. Review.
Fenofibrate: a review of its use in primary dyslipidaemia, the metabolic syndrome and type 2 diabetes mellitus.
Keating GM, Croom KF. Keating GM, et al. Drugs. 2007;67(1):121-53. doi: 10.2165/00003495-200767010-00013. Drugs. 2007. PMID: 17209672 Review.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information